Titan Medical Inc. (TMD.TO)
Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
As of 11:29AM EST. Market open.
Currency in CAD
Valuation Measures4
| Market Cap (intraday) | 59.30M |
| Enterprise Value | 45.75M |
| Trailing P/E | 26.54 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 4.42 |
| Price/Book (mrq) | 6.39 |
| Enterprise Value/Revenue | 4.57 |
| Enterprise Value/EBITDA | -2.29 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 3.58 |
| 52-Week Change 3 | -41.11% |
| S&P500 52-Week Change 3 | -13.51% |
| 52 Week High 3 | 1.0000 |
| 52 Week Low 3 | 0.4900 |
| 50-Day Moving Average 3 | 0.5962 |
| 200-Day Moving Average 3 | 0.6480 |
Share Statistics
| Avg Vol (3 month) 3 | 6.6k |
| Avg Vol (10 day) 3 | 7.85k |
| Shares Outstanding 5 | 111.89M |
| Implied Shares Outstanding 6 | N/A |
| Float 8 | 111.61M |
| % Held by Insiders 1 | 0.10% |
| % Held by Institutions 1 | 3.74% |
| Shares Short (Nov 14, 2022) 4 | 92.43k |
| Short Ratio (Nov 14, 2022) 4 | 11.85 |
| Short % of Float (Nov 14, 2022) 4 | 0.08% |
| Short % of Shares Outstanding (Nov 14, 2022) 4 | 0.08% |
| Shares Short (prior month Oct 13, 2022) 4 | 92.22k |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | Jun 18, 2018 |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | 1:30 |
| Last Split Date 3 | Jun 18, 2018 |
Financial Highlights
Currency in USD.Fiscal Year
| Fiscal Year Ends | Dec 30, 2021 |
| Most Recent Quarter (mrq) | Sept 29, 2022 |
Profitability
| Profit Margin | -210.43% |
| Operating Margin (ttm) | -378.68% |
Management Effectiveness
| Return on Assets (ttm) | -69.45% |
| Return on Equity (ttm) | -129.90% |
Income Statement
| Revenue (ttm) | 10M |
| Revenue Per Share (ttm) | 0.09 |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 20.09M |
| EBITDA | -37.35M |
| Net Income Avi to Common (ttm) | -21.04M |
| Diluted EPS (ttm) | -0.1100 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 11.64M |
| Total Cash Per Share (mrq) | 0.1 |
| Total Debt (mrq) | 1.48M |
| Total Debt/Equity (mrq) | 21.28 |
| Current Ratio (mrq) | 1.41 |
| Book Value Per Share (mrq) | 0.06 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -31.97M |
| Levered Free Cash Flow (ttm) | -33.37M |
© 2022 Yahoo. All rights reserved.
